Q4 2018 Holdings
Filed 2019-02-14 | 14 holdings | $25.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $13.2M | 1,064,928 | 51.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.9M | 524,763 | 30.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.4M | 45,806 | 17.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $107.6K | 1,500,000 | 0.4% |
| Merus N V | COM | N5749R100 | $20.7K | 1,480,855 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $11.8K | 408,729 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $9.4K | 1,334,179 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $8.9K | 697,096 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $6.3K | 1,031,947 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.0K | 951,527 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $3.5K | 24,750 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.3K | 35,920 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $3.2K | 1,210,837 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $298 | 11,787 | 0.0% |